(Press-News.org) Parkinson's disease has always been considered a brain disorder. However, new research reveals a close link between the disease and certain immune cells in the blood.
Researchers from Aarhus University have taken the first step on a path which can lead to new ways of understanding and, in the long term, possibly treating this widespread disease that affects not only motor functions but also cognition and emotions.
"We know that Parkinson's disease is characterized by an inflammation in the brain, and that this is crucial for the progression of the disease. But in the study, our interest has been focused on the immune cells found outside the brain," explains Marina Romero-Ramos, who is associate professor at the Department of Biomedicine at Aarhus University.
The researchers have studied a group of patients suffering from REM Sleep Behaviour Disorder (RBD), a condition where the patients physically act vivid dreams with vocalizations and movements. If a patient e.g. dreams that they are running, their legs will move as if they were actually running. The sleep disorder is often discovered by a spouse as it results in violent movements at night, and the diagnosis is often indicative of something more. Patients with RBD have a high risk of developing Parkinson's - statistically approximately ninety per cent of them will be diagnosed with a parkinsonism related disorder over the course of 5-10 years.
The blood's immune system changes very early on
In Parkinson's disease, a protein called alpha-synuclein aggregates in the neurons in the brain, and this kills the cells. The same protein also aggregates in the brain of people with the RBD, and it is therefore regarded as an early form of Parkinson's disease. This has led the researchers from the Department of Biomedicine at Aarhus University - in collaboration with a group of neurologists and experts in nuclear medicine at Aarhus University Hospital, led by Dr. Nicola Pavese - to carry out scans of the brains of 15 patients with RBD and ten healthy people. The scan revealed that the patients with the sleep disorder had inflammation and a loss of neuronal activity in the brain. Although they did not present symptoms of Parkinson's, their neurons were already ill and the brain's immune cells were activated.
The groundbreaking discovery happened when Dr. Marina Romero-Ramos and her colleagues from Aarhus University analysed blood samples from these patients. It turned out that the inflammation in the brain, and the associated loss of brain cells, directly related to changes in some immune cells in the blood, the monocytes. When certain proteins increased on these immune cells, there was in parallel increased inflammation in the brain and a decrease on the neuronal activity. This is a key finding when it comes to understanding Parkinson's disease.
"We could see that the blood's immune system changes very early on - even before Parkinson's is diagnosed," says Marina Romero-Ramos.
"This is the first study to show that the body's immune system continuously communicates with the brain during the development of Parkinson's disease, and that changes in the body's immune system influence the condition of the neurons in the brain. In connection with Parkinson's, this presents us with new opportunities for studying the immune cells in the blood and finding new forms of treatment," she says.
This means that the researchers now hope to find and investigate ways to influence Parkinson's disease by treating the blood and not the brain. Previous experiments on mice and rats suggest that this is possible, even though there is still much research to be done, as Dr. Romero-Ramos explains.
"This opens up the possibility of being able to design immunotherapy that modulates cells in the blood, which subsequently would stop or delay the changes in the brain. For the patients, being able to enjoy more years with good quality of life will be very significant," she says.
"It also opens up opportunities for us to be able to find biomarkers in the blood that can tell us how someone's brain is doing. Blood tests can be done more often and cheaper than a brain scan."
Rare data from patients
The brain is a special type of tissue, and for many years researchers believed that the immune response in the brain was independent from the rest of the body. The study has now confirmed that the immune response in the brain and the body communicate with each other during RBD, and this is a discovery that the researchers could not have made without the help of the volunteers that took part in the study.
"We've had a unique combination of researchers at Aarhus University Hospital who take images of the brain, and researchers like me who analyse immune cells in the blood. It is very rare to get both analyses from a patient and it has only been possible because a group of people were willing to participate in the trial, which we're very grateful for. Participation involved two visits to the hospital for a brain scan, which itself isn't painful, but of course it requires time and patience," says Marina Romero-Ramos.
The data should be now evaluated and replicated by more labs, and hopefully new groups of patients will provide blood samples, brain scans and their patience for further testing.
"This lays the foundation. We can continue to build on the study, because we've now discovered that there is a change in the blood at a very early stage of Parkinson's disease, and that it's related to changes in the brain. We didn't have the data to truly say this before."
INFORMATION:
The research results - more information
The study has just been published in the American scientific journal Proceedings of the National Academy of Sciences (PNAS): https://www.pnas.org/content/118/10/e2020858118
The study is a case-control study of healthy individuals and patients with REM Sleep Behaviour Disorder who were recruited at the Hospital Clinic of Barcelona (Spain) and Aarhus University Hospital (Denmark).
The patients underwent PET scans under the supervision of Professor Nicola Pavese at the Department of Clinical Medicine - PET Centre (AUH). The blood analysis was carried out in Marina Romero-Ramos' lab at the Department of Biomedicine at Aarhus University. The study was carried out in collaboration with Dr. Eduardo Tolosa's team at CIBERNED and The Parkinson Disease and Movement Disorder Unit, Neurology Service, Hospital Clinic de Barcelona, University of Barcelona in Spain.
The studies were approved by the local ethics committee at both centres, and all participants gave their consent in accordance with the Helsinki declaration before registration.
The study is supported by the Aarhus University Research Foundation, the Danish Council for Independent Research, the Lundbeck Foundation and the Jascha Foundation.
Contact
Associate Professor & DANDRITE Affiliated Researcher Marina Romero-Ramos
Department of Biomedicine at Aarhus University
Email: mrr@biomed.au.dk
Mobil: (+45) 6020 2749
COVID-19 pandemic has increased loneliness and other social issues, especially for women, Mayo research finds
ROCHESTER, Minnesota -- Social distancing guidelines have reduced the spread of COVID-19, but lockdowns and isolation also have created or aggravated other well-being concerns, reports new research. Mayo Clinic investigators found a significant increase in loneliness and a decrease in feelings of friendship during the pandemic. The study, published Feb. 20 in the journal Social Science & Medicine, also showed disproportionate negative effects among women and those with poorer health.
The researchers say that while physical distance is important during the pandemic, distance within and among relationships can cause undue harm to a person's mental health and well-being. ...
Astronomers using the recently installed instrument MAROON-X on Gemini North have determined the mass of a transiting exoplanet orbiting the nearby star Gliese 486. As well as putting the innovative new instrument through its paces, this result, when combined with data from the TESS satellite, precisely measures key properties of a rocky planet that is ideal for follow-up observations with the next generation of ground- and space-based telescopes.
The exoplanet-hunting instrument MAROON-X has obtained its first scientific result from its new home ...
What The Study Did: This randomized clinical trials reports that among adults with mild COVID-19, a five-day course of ivermectin, compared with placebo, didn't significantly improve the time to resolution of symptoms. The findings don't support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand the effects of ivermectin on other clinically relevant outcomes.
Authors: Eduardo López-Medina, M.D., M.Sc., of the Centro de Estudios en Infectología Pediátrica in Cali, Colombia, is the corresponding author.
To access the embargoed ...
What The Article Says: Current best evidence about COVID-19 vaccines, immunity and whether SARS-CoV-2 will become an endemic or seasonal virus is summarized in this Viewpoint.
Authors: Carlos del Rio, M.D., of the Emory University School of Medicine in Atlanta, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2021.3760)
Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
INFORMATION:
Media advisory: The full article is linked to this news release.
Embed ...
In less than a second, a small sensor used in brain chemistry research can detect the key molecules that provide the genetic instructions for life, RNA and DNA, a new study from American University shows.
The AU researchers believe the sensor is a useful tool for scientists engaged in clinical research to measure DNA metabolism, and that the sensor could be a quick way for lab clinicians to distinguish 'healthy' from 'sick' samples and determine if a pathogen is fungal, bacterial, or viral, before conducting further analysis.
To explore whether the sensors could detect RNA and DNA, ...
The Pazyryk carpet is the world's oldest example of a knotted-pile carpet and is kept at the State Hermitage Museum in St. Petersburg, Russia. The carpet, which was made out of new wool at around 400 BC, is one of the most exciting examples of central Asian craftsmanship from the Iron Age. Ever since the carpet was discovered in 1947 by Russian archaeologists in a kurgan tomb in the Altai mountains, experts in traditional dyeing techniques have been puzzled by the vivid red, yellow and blue colours of the carpet, which lay buried in extreme conditions for almost two thousand five hundred years.
Red fibres ...
You didn't need a Ph.D. to contribute to research into wildlife abundance and behavior in North Carolina, thanks to a large-scale citizen science project led by North Carolina State University researchers.
Through the project, called North Carolina Candid Critters, researchers trained 580 volunteers to take candid animal photos with heat sensitive cameras, and then share their photos through a website called eMammal. In an article on the project in the journal Citizen Science: Theory and Practice, researchers reported on the successes and challenges of the effort, which gathered more than 2.2 million wildlife photos across three years, and increased the number of verified mammal records that were available in the state by a factor of five.
"The power of this is that you can get ...
What The Article Says: This Viewpoint proposes ways to maximize vaccine efficacy and allocation given the rise of coronavirus variants and authorization of a Johnson & Johnson vaccine, including reserving the latter for younger healthier populations, boosting it with a single-dose messenger RNA (mRNA) vaccination and single mRNA immunization of people with prior documented SARS-CoV-2 infection.
Authors: John P. Moore, Ph.D., of Weill Cornell Medicine in New York, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2021.3465)
Editor's Note: The article includes an Editor's Note. Please see the article for additional information, including other authors, author ...
Many cognitive neurodevelopmental disorders are a result of too many or too few copies of certain genes or chromosomes. To date, no treatment options exist for this class of disorders. MECP2 duplication syndrome (MDS) is one such disorder that primarily affects boys and results from a duplication spanning the methyl-CpG binding protein 2 (MECP2) locus located on the X chromosome.
A preclinical study published from the laboratory of Dr. Huda Zoghbi, professor at Baylor College of Medicine and director of the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, provides experimental evidence that supports the use of antisense oligonucleotides as ...
BOSTON - New treatments for Alzheimer's disease are desperately needed, but numerous clinical trials of investigational drugs have failed to generate promising options. Now a team at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) has developed an artificial intelligence-based method to screen currently available medications as possible treatments for Alzheimer's disease. The method could represent a rapid and inexpensive way to repurpose existing therapies into new treatments for this progressive, debilitating neurodegenerative condition. ...
